InsiderPulseNo transactions found.
No financial data available for MNK.
Company may not file with SEC or CIK is unresolved.
Mallinckrodt plc 2025 Q4 - Results - Earnings Call Presentation
Keenova expects $1.94B-$2.0B 2026 net sales and targets NYSE listing in H2 2026
Mallinckrodt plc (MNKTQ) Q4 2025 Earnings Call Transcript
Mallinckrodt plc (MNKTQ) Q3 2025 Earnings Call Prepared Remarks Transcript
Mallinckrodt GAAP EPS of -$9.01, revenue of $753.1M
Mallinckrodt GAAP EPS of $0.11, revenue of $485.1M
Mallinckrodt reports Q1 results
Notable healthcare headlines for the week: Merck, Novo Nordisk, J&J and Roche in focus